Transcriptomics

Dataset Information

0

Phase I/Ii study of mTOR inhibitor everolimus and Hyper-CVAD plus RAD001 (Everolimus) chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia


ABSTRACT: Analysis of the effects of everolimus on gene expression and if this correlates to drug and/or clinical response.

ORGANISM(S): Homo sapiens

PROVIDER: GSE60540 | GEO | 2017/01/01

SECONDARY ACCESSION(S): PRJNA258503

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| S-EPMC4470787 | biostudies-literature
| S-EPMC7337242 | biostudies-literature
2013-11-12 | E-MEXP-3802 | biostudies-arrayexpress
| S-EPMC5948762 | biostudies-literature
| S-EPMC5581027 | biostudies-literature
2018-08-30 | GSE119262 | GEO
2015-09-09 | E-GEOD-66107 | biostudies-arrayexpress
2024-10-31 | GSE271325 | GEO
| S-EPMC9729240 | biostudies-literature